Table Of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Atopic Dermatitis Market: By Disease Type Trends, Size, and Future Outlook
- By Disease Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Disease Type Definitions, Technology Landscape
- By Disease Type Market Drivers
- Product Launches
- Technology Launches
- By Disease Type Market Restraints
Chapter 4. Atopic Dermatitis Market: By Treatment Type Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
- Product Launches
- Technology Launches
- By Treatment Type Market Restraints
Chapter 5. Atopic Dermatitis Market: By Route of Administration Trends, Size, and Future Outlook
- By Route of Administration Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Route of Administration Definitions, Technology Landscape
- By Route of Administration Market Drivers
- Product Launches
- Technology Launches
- By Route of Administration Market Restraints
Chapter 6. Atopic Dermatitis Market: By Distribution Channel Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
Chapter 7. Atopic Dermatitis Market: By Drug Class Trends, Size, and Future Outlook
- By Drug Class Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Drug Class Definitions, Technology Landscape
- By Drug Class Market Drivers
- Product Launches
- Technology Launches
- By Drug Class Market Restraints
Chapter 8. Atopic Dermatitis Market: By End User Trends, Size, and Future Outlook
- By End User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End User Definitions, Technology Landscape
- By End User Market Drivers
- Product Launches
- Technology Launches
- By End User Market Restraints
Chapter 9. Atopic Dermatitis Market: Regional Market Trends, Size, and Future Outlook
- North America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Europe
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Asia Pacific
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Latin America
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
- Middle East, and Africa
- Trends, Market Size (US$), CAGR (%), and Future Outlook
- Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Definitions, Technology Landscape
- Market Drivers
- Product Launches
- Technology Launches
- Market Restraints
- Competitive Outlook
Chapter 10. Atopic Dermatitis Market: Competitive Landscape
- Sanofi
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Regeneron Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- AbbVie
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Eli Lilly and Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- LEO Pharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bausch Health Companies
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Galderma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Mayne Pharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Mylan
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Almirall
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Astellas Pharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Anaptys Bio
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Incyte Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- BioVersys
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sienna Biopharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Arcutis Biotherapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Atopic Dermatitis industry is USD 10.2 billion in 2023.
Rising prevalence, increasing awareness, robust pipeline, urbanization, pollution, changing lifestyles, economic development, and improving healthcare infrastructure.
High treatment costs, stringent regulatory approvals, side effects of existing treatments, and limited access in developing regions.
The leading component segment is the topical treatments segment, widely used as first-line therapy.
Sanofi, Regeneron Pharmaceuticals, Pfizer, AbbVie, Eli Lilly and Company, Novartis, LEO Pharma, Bausch Health Companies, Galderma, Mayne Pharma.
The Atopic Dermatitis Market is expected to grow at a CAGR of 13.8% from 2024 to 2031, reaching a market size of US$ 28.7 billion by 2031.
Rising prevalence, increasing awareness, robust pipeline, urbanization, pollution, changing lifestyles, economic development, and improving healthcare infrastructure.